Evidence map›Paper›PMID 37669097›Full record

ArticleAnnals of medicine2023

Investigation of the prevalence and risk factors of

Foqiang Liao, Zhenhua Zhu, Shusheng Zhu, Jianhua Wan, Chenglai Fan, Xu Zhang, Xu Shu, Nonghua Lu

Open access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Exploration of the role ofFrontiers in pharmacology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Foqiang LiaoDepartment of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.
Zhenhua ZhuDepartment of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.
Shusheng ZhuDepartment of Gastroenterology, Yudu County People's Hospital, Ganzhou, Jiangxi, P.R.China.
Jianhua WanDepartment of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.
Chenglai FanDepartment of Gastroenterology, Yudu County People's Hospital, Ganzhou, Jiangxi, P.R.China.
Xu ZhangDepartment of Gastroenterology, Yudu County People's Hospital, Ganzhou, Jiangxi, P.R.China.
Xu ShuDepartment of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.ORCID 0000-0002-0861-5742
Nonghua LuDepartment of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.
Nanchang University · CNGanzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this current study was to identify the prevalence and risk factors of

methodsAn epidemiological study was conducted in Yudu County, Jiangxi, China, and participants were followed up for 6 years. All participants completed a questionnaire, laboratory tests and endoscopy. Patients were divided into

resultsA total of 1962 residents were included, the prevalence of

conclusionsIn a low-risk area of gastric cancer in China, the infection rate of

Indexed as

Helicobacter InfectionsStomach NeoplasmsAdultAgedChinaEarly Detection of CancerFemaleHelicobacter pyloriHumansMaleMiddle AgedPrevalenceRisk Factorsepidemiological surveygastric cancerHelicobacter pyloririsk factorscreening method

Identifiers

PMID37669097
PMCPMC10481759
OpenAlexW4386437836

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.